|
Volumn 28, Issue 12, 2001, Pages 2573-2575
|
Rheumatoid arthritis, methotrexate, and lymphoma: Risk substitution, or cat and mouse with Epstein-Barr virus?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
METHOTREXATE;
RITUXIMAB;
CELLULAR IMMUNITY;
DISEASE ACTIVITY;
EDITORIAL;
EPSTEIN BARR VIRUS;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
INFLAMMATION;
LYMPHOMA;
LYMPHOPROLIFERATIVE DISEASE;
NONHODGKIN LYMPHOMA;
ORGAN TRANSPLANTATION;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
RISK FACTOR;
SURVIVAL;
ARTHRITIS, RHEUMATOID;
BURKITT LYMPHOMA;
EPSTEIN-BARR VIRUS INFECTIONS;
HERPESVIRUS 4, HUMAN;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSIVE AGENTS;
METHOTREXATE;
RISK;
|
EID: 0035203725
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (27)
|
References (28)
|